{"nct_id":"NCT06021054","title":"An Efficacy, Safety, and Tolerability Study of Veligrotug (VRDN-001), in Participants With Chronic Thyroid Eye Disease (TED) (THRIVE-2)","status":"ACTIVE_NOT_RECRUITING","status_verified_date":"2025-04","start_date":"2023-11-14","start_date_type":"ACTUAL","primary_completion_date":"2024-12-05","primary_completion_date_type":"ACTUAL","completion_date":"2025-08","completion_date_type":"ESTIMATED","phases":["PHASE3"],"tickers":["VRDN"]}